ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

Leading the Way in Specialized Diabetic Foot Care in Delhi NCRDelhi, India - November 17, 2024 — Diabetes, often called the ...

JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on November 13. Debanjana ...

Clene (NASDAQ:CLNN – Free Report) had its price target cut by Canaccord Genuity Group from $86.00 to $83.00 in a research report released on Thursday morning,Benzinga reports. They currently have a ...

completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial ...

Come out and audition and experience the fun of community theater in Carson City on Tuesday, Nov. 19 at 6 p.m. and Saturday, ...

Come out and audition and experience the fun of community theater in Carson City on Tuesday, Nov. 19 at 6 p.m. and Saturday, ...

Unexpected cardiovascular complications: Manipulating the neck can sometimes affect blood flow and lead to unexpected ...

"Zero Candida has a potential to become a technological leader and use its ground-breaking technology to expand boundaries of non-chemical candida treatment," added Mr ... biologic therapy to treat ...

Medically reviewed by Katrina Carter, DPT Reflexology is a complementary and alternative medicine (CAM) therapy. It's a type ...

Completed Enrollment of Dose Escalation Part of Phase 1 Clinical Trial of its Next-Generation Nectin-4 Targeting ADC (CRB-701 ...